Maravai Lifesciences Holdings (MRVI) Return on Sales (2020 - 2025)
Historic Return on Sales for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 1.08%.
- Maravai Lifesciences Holdings' Return on Sales rose 14200.0% to 1.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.11%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 1.0% for FY2024, which is 5200.0% down from last year.
- According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Return on Sales is 1.08%, which was up 14200.0% from 1.47% recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Return on Sales ranged from a high of 0.65% in Q2 2022 and a low of 2.5% during Q3 2024
- Over the past 5 years, Maravai Lifesciences Holdings' median Return on Sales value was 0.17% (recorded in 2023), while the average stood at 0.26%.
- As far as peak fluctuations go, Maravai Lifesciences Holdings' Return on Sales crashed by -22700bps in 2024, and later soared by 14200bps in 2025.
- Over the past 5 years, Maravai Lifesciences Holdings' Return on Sales (Quarter) stood at 0.56% in 2021, then dropped by -23bps to 0.43% in 2022, then crashed by -447bps to 1.48% in 2023, then soared by 45bps to 0.81% in 2024, then tumbled by -33bps to 1.08% in 2025.
- Its Return on Sales was 1.08% in Q3 2025, compared to 1.47% in Q2 2025 and 1.13% in Q1 2025.